Brief: Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering
Feb 7 (Reuters) - Collegium Pharmaceutical Inc COLL.O :
* COLLEGIUM PHARMACEUTICAL, INC. PRICES UPSIZED $210.0
MILLION
CONVERTIBLE SENIOR NOTES OFFERING
* OFFERING WAS UPSIZED FROM PREVIOUSLY ANNOUNCED OFFERING
SIZE OF
$175 MILLION AGGREGATE PRINCIPAL AMOUNT OF NOTES
* PRICING OF ITS OFFERING OF $210 MILLION AGGREGATE
PRINCIPAL
AMOUNT OF 2.875% CONVERTIBLE SENIOR NOTES DUE 2029
Source text for Eikon: ID:nGNX4fQTsr
Further company coverage: COLL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%